Background/Aims: Psychological stress has previously been associated with higher risk of developing late-life dementia, especially Alzheimer's disease (AD). This study tested whether longstanding midlife stress is related to cerebrospinal fluid (CSF) biomarkers of late-life AD, such as tau protein and amyloid beta (Aβ). Methods: The study included 79 nondemented females from the Prospective Population Study of Women in Gothenburg, Sweden, who responded to a standardized stress question at baseline (mean age 49 years) and underwent a lumbar puncture at follow-up 25 years later. Multiple linear regression models analyzed the relationships between midlife psychological stress and late-life CSF measures of total tau (t-tau), phosphorylated tau (p-tau), Aβ40, and Aβ42. Results: Longstanding stress in midlife was associated with higher levels of CSF t-tau (β = 0.64, p = 0.01) and Aβ40 (β = 0.60, p = 0.02) in late life. No associations were found between midlife stress and levels of p-tau or Aβ42.
Introduction
Chronic and severe psychological stress may trigger neurodegenerative processes in the brain. We have previously reported associations between longstanding stress and late-life dementia, especially Alzheimer's disease (AD) [1] , and late-life structural brain changes, such as temporal lobe atrophy and white matter lesions [2] . We have also found that high neuroticism, a stress-prone personality trait, and increased number of stressful life events were related to AD risk [3, 4] . Other longitudinal studies have reported associations between stress disorders (e.g., posttraumatic stress disorder), stress-prone personality, and dementia [5, 6] .
There are several hypotheses regarding the mechanisms by which psychological stress may increase the risk of neurodegenerative disorders, such as AD. One is that longstanding exposure to stress hormones may have damaging effects on brain areas with a large number of glucocorticoid receptors, e.g., the median temporal lobe and the hippocampus area [7] . Neurodegeneration in those areas is an early marker for AD. Stress has also been associated with vascular factors [8] and inflammatory processes [9] in the brain, which are both related to AD.
In animal studies, it has been found that chronic stress was associated with accumulation of amyloid beta (Aβ) and tau proteins in brains of mice [10, 11] . No study has thus far analyzed the effect of psychological stress on specific AD markers, such as Aβ and tau protein, in aging human brains. However, two studies analyzed the effects of stress in postmortem brains. One study found that persons with stress-prone personality had a more advanced stage of neurofibrillary tangle formation [12] , while the other found no associations with neither neurofibrillary tangles nor amyloid plaques [13] .
AD is characterized by accumulation of Aβ in the brain. This accumulation may be due to overproduction, as seen in familial AD [14] , or by reduced clearance. There are two major variants of Aβ, with either 1-40 (Aβ40) or 1-42 (Aβ42) amino acid residues. The more soluble Aβ40 accumulates as cerebral amyloid angiopathy, whereas the less soluble Aβ42 is mainly found in senile plaques [15] . Aβ42 has the highest tendency for aggregation and plaque formation. Low levels of Aβ42 in cerebrospinal fluid (CSF) are related to AD and are believed to reflect accumulation of senile plaques in brain parenchyma [16, 17] . Aβ40, on the other hand, is the most abundant Aβ peptide [18] . Its biochemical function is unclear, but high levels of Aβ40 are suggested to reflect Aβ overproduction and amyloid precursor protein (APP) dysfunction [19] . The total concentration of tau (t-tau) in CSF is thought to reflect the intensity of neuronal degeneration. Increased levels of t-tau are seen in AD, but also in other brain disorders, e.g., in vascular dementias [20] . Increased levels of phosphorylated tau (p-tau) are thought to reflect accumulation of neurofibrillary tangles in the brain and are a more specific sign of AD [21] . It is not clear whether stress affects these CSF biomarkers of AD.
More knowledge on how risk factors for AD affect these biological markers is needed. Prospective studies on stress and its associations with the central pathogenic processes during the preclinical phase of AD are lacking. Therefore, we examined the relationships between longstanding midlife stress and late-life levels of CSF t-tau, p-tau, Aβ40, and Aβ42 in a sample of nondemented women followed for 25 years.
Subjects and Methods

Study Population
The sample was derived from the Prospective Population Study of Women in Gothenburg, Sweden, which was initiated in 1968 (n = 1,462). This study included several follow-up examinations conducted over more than four decades [1, 22] . Participants were initially sampled from the Swedish Population Register based on specific birth dates in order to yield a representative sample at the ages studied (mean age 46 years). A standardized question about longstanding stress was included at baseline in 1968. In the followup examination in 1992-94, 590 women participated in an extensive neuropsychiatric examination, and 86 of those consented to a lumbar puncture (LP) [23] . Participants and nonparticipants in the LP examination were similar regarding baseline diastolic and systolic blood pressure, body mass index, smoking habits, cardiovascular disease (CVD), depressive symptoms, and report of longstanding stress. They had also similar Mini-Mental State Examination (MMSE) scores at the 1992-94 examination. LP participants were younger (p > 0.01), had higher education (p = 0.04), developed dementia less often (after follow-up examination), and had a lower 5-year mortality rate (p = 0.02) compared to nonparticipants. The present study consisted of 79 women (born in 1908 [n = 2], 1914 [n = 7] , 1918 [n = 33], and 1922 [n = 37]). Five women were excluded due to missing stress data and two were excluded due to dementia. Anonymized data and details about the analyses will be made available to colleagues if requested.
Assessment of Longstanding Psychological Stress
At baseline, a physician asked the women about periods of psychological stress. The question was, "Have you experienced any period of stress, one month or longer, in relation to circumstances in everyday life, such as work, health, or family situation?" Stress was defined as feelings of irritability, tension, nervousness, fear, anxiety, or sleep disturbances. The responses were categorized as follows: 0, never a period of stress; 1, period/s of stress > 5 years ago; 2, one period of stress during the last 5 years; 3, several periods of stress during the last 5 years; 4, constant stress during the last year; or 5, constant stress during the last 5 years. For the purpose of this study, women who acknowledged responses 3, 4, or 5 were considered to have suffered psychological stress.
Assessment of CSF Biomarkers
The LP examinations were conducted between January 1993 and March 1994. CSF samples (12 mL) were taken through the L3/L4 interspace. To eliminate cells and other insoluble material, the samples were centrifuged at 2,000 g for 10 min. The liquid was then stored at -80 ° C in 1-mL polypropylene vials until analyses. Within 5 years after the LP examination, the CSF was analyzed for biomarkers [23] . Sandwich enzyme-linked immunosorbent assay was used to determine levels of t-tau, p-tau, Aβ40, and Aβ42 [23, 24] . The procedure has been described in detail previously [23] .
Other Measures
Information on educational level (compulsory versus more than compulsory), CVD (documented history of myocardial infarction and/or angina pectoris and/or ECG evidence of ischemia), hypertension (systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥80 mm Hg and/or taking antihypertensive medications), and major depression (DSM-III criteria for major depressive disorders, based on information from psychiatrist interviews [25] ) was assessed at baseline. The MMSE score was calculated at the follow-up examination in 1992-94. In a subsample of 51 women, data on apolipoprotein E (ApoE) allele status (presence or absence of the ɛ4 allele) were available.
Statistical Analyses
Due to skewed distributions, t-tau and p-tau values were natural log transformed to improve symmetry. Means, standard deviations, and median levels were determined for all CSF levels. Linear regression models (β-coefficient and p value) analyzed the relationships between baseline covariates, i.e., age, education level, major depression, CVD/hypertension, and ApoE ɛ4, and CSF biomarkers at follow-up.
The associations between psychological stress and CSF biomarkers (t-tau, p-tau, Aβ40, Aβ42, and Aβ42/Aβ40 ratio) were analyzed with multiple linear regression models in three separate models. The first model was adjusted for age; the second model was adjusted for age, education, and depression; and the third model was adjusted for age, education, depression, and CVD/hypertension. Model 3 was also adjusted for ApoE ɛ4 genotype (in the subsample of persons with DNA information). Model 3 was additionally examined after excluding cases with extremely high t-tau and Aβ40 values (i.e., outliers). The results were presented as β-coefficients and 95% confidence intervals, and statistical significance was defined as a p value < 0.05. Finally, a linear regression model analyzed MMSE score in relation to stress and CSF measurements. All analyses were performed with the IBM SPSS version 24 statistical software (Armonk, NY, USA).
Results
The mean age at baseline of the 79 participants was 49 years (range 46-60). At followup, the mean age was 74 years (range 71-85). At baseline, 18 participants reported longstanding psychological stress, 8 had depression, 62 were diagnosed with CVD and/or hypertension, and 29 had more than compulsory education. In the subsample of 51 participants with DNA information, 16 were ApoE ɛ4 carriers (Table 1) . Table 1 presents the means (standard deviations) and median values for t-tau, p-tau, Aβ40, Aβ42, and Aβ42/Aβ40 ratio for the total sample and for persons with psychological stress. Higher age was associated with higher levels of CSF t-tau (p = 0.01), p-tau (p = 0.04), and Aβ40 (p < 0.01), and lower Aβ42/Aβ40 ratio (p = 0.05) ( Table 2 ). Major depression in midlife was associated with a higher Aβ42/Aβ40 ratio (p = 0.04).
In multiadjusted regression models, it was found that persons with longstanding midlife stress had higher levels of t-tau (β = 0.64, p = 0.01) and Aβ40 (β = 0.60, p = 0.02) in late life (Table 3) . Midlife stress was not associated with p-tau (β = 0.25, p = 0.32), Aβ42 (β = 0.42, p = 0.14), or Aβ42/Aβ40 ratio (β = -0.02, p = 0.83). Stress was associated with t-tau (β = 0.85, p = 0.02) and Aβ40 (β = 0.78, p = 0.04) also after adjustment for ApoE genotype.
The box plots in Figures 1 and 2 illustrate the distribution of t-tau ( Fig. 1) and Aβ40 (Fig. 2) in the nonstressed and stressed groups (i.e., median, 25th and 75th percentiles, and minimum/maximum levels). Outliers are present in both figures. When excluding the three outliers with very high t-tau (> 800 pg/mL), the association between midlife stress and higher t-tau remained (β = 0.57, p = 0.02). Also, when excluding 1 person with very high Aβ40 (21,331 pg/mL), the association between midlife stress and high Aβ40 remained (β = 0.63, p < 0.01). Women with midlife stress scored lower on late-life MMSE than women without midlife stress (27.7 vs. 28.6, p < 0.01). The association between midlife stress and higher t-tau (β = 0.55, p = 003) and Aβ40 (β = 0.55, p = 0.04) remained in a model adjusted for age and late-life MMSE score.
Discussion
In a nondemented sample of women followed for 25 years, we found that longstanding midlife stress was associated with higher levels of CSF t-tau and Aβ40 in late life, but not with the more specific AD markers p-tau and Aβ42. The association remained after further adjustments for age, education, depression, CVD, hypertension, MMSE score, and ApoE genotype. To the best of our knowledge, this is the first study to examine midlife stress in relation to late-life CSF levels of tau and Aβ. We have previously reported associations between midlife stress and late-life dementia [1] , AD [1] , temporal lobe atrophy [2] , and white matter lesions [2] . Here, we extent these previous findings by showing that midlife stress is even related to CSF biomarkers in later life. It must be emphasized that these associations occur very early in the disease process, before clinical manifestations of AD or other subtypes of dementia.
The finding that midlife stress is related to increased levels of CSF t-tau suggests that stress may affect the risk of AD by inducing unspecific neurodegeneration, rather than AD pathology, before dementia onset. This is in line with our previous report that midlife stress increases the risk of brain atrophy among women without dementia [2] . An increase in t-tau has been found in many studies of dementia disorders [26] . It has been suggested that t-tau increases decades before onset of clinical AD, but appears later than CSF Aβ42 decline [17] . A higher concentration of t-tau can be regarded as a general marker for neural disintegration and degeneration, and it occurs in brain damage disorders of varied etiology [11] . It may be that stress influences neuronal function, as reflected by diffusion of tau, long before the onset of dementia. We found no associations between stress and levels of CSF p-tau. Increased concentration of p-tau is a more specific marker for formation of neurofibrillary tangles (compared to t-tau) and is more commonly affected in AD compared to other dementia disorders such as vascular dementia [21] . However, high levels of p-tau are normally seen in developed states of the neurodegenerative processes, e.g., when amyloid has started to aggregate in plaques and AD is more manifest [21] .
We also found that midlife stress was associated with higher levels of late-life Aβ40, which is the most abundant form of Aβ and reflects the total amount of Aβ being produced from APP. A higher level of CSF Aβ40 may be understood as the reflection of a general overproduction of Aβ from APP [27] . This may increase the risk of having the Aβ aggregation cascade taking off, similar to what has been described in familial AD [28] . The absence of an association between stress and the CSF Aβ42/Aβ40 ratio, the best-validated amyloid plaque pathology marker [19] , could potentially suggest that stress may increase the risk of Aβ aggregation taking place (through increased amyloidogenic APP processing, reflected by increased Aβ40), but that this has not translated into factual Aβ pathology yet (no association with Aβ42 or the Aβ42/Aβ40 ratio).
This study found no evidence of associations between stress and CSF Aβ42. It has been suggested that Aβ42 levels are higher several decades before dementia onset and then start to decline 20 years before clinical symptoms [17, 29] . Maybe early high levels of CSF Aβ42 mirror high amyloid production, while lower levels reflect disturbed metabolism and plaque pathology [17, 30] . The levels of Aβ42 are thus very much dependent on "time to dementia onset." In our study, all participants were free from dementia and might thus have variable time until dementia onset. Plaque accumulation can theoretically be due to Aβ42 overproduction, as seen in familial AD [14] , or defective clearance. The available data so far suggest that Aβ clearance from the brain is impaired in symptomatic sporadic AD, whereas Aβ production seems unaltered [31] . No solid data on production and clearance rates in preclinical sporadic AD exist.
The results of this study are difficult to compare to those of other studies, as very few studies have been done on midlife risk factors for asymptomatic late-life CSF AD biomarkers in normal individuals. Two autopsy studies examined the effect of neuroticism, a personality trait associated with stress proneness, on AD pathology. One longitudinal study [12] , with a mean follow-up of 11 years, found that high neuroticism was associated with more advanced stages of neurofibrillary tangles postmortem, but in contrast, another study reported that neither levels of neurofibrillary tangles nor amyloid plaques were associated with proneness to stress [32] . In contrast to these studies, our sample was younger and all participants were free from dementia. 
Strengths and Limitations
The strengths of this study include a population-based sample, long follow-up, and information already from midlife. Some methodological issues need however to be considered. First, psychological stress was based on a subjective personal response to a single question. Our question on stress has however been used in several previous studies and is found to be related to a number of life stressors and high neuroticism [3, 4] . Second, all analyses were conducted in relatively small samples, resulting in low statistical power. The results may therefore be underpowered to detect small differences between groups. The ability to adjust for possible confounders was also limited. Third, we only had CSF data from the follow-up examination in 1993-94 and no data before or after this examination. Fourth, cumulative attrition is a problem in long-term follow-up studies, and the participation in the LP study was only 10% of the eligible sample. Fifth, as CSF biomarkers were measured in late life, we cannot exclude the possibility of survival effects. We can thus not generalize to other groups.
Conclusion
Our results suggest that longstanding stress can stimulate unspecific neurodegenerative processes, but not the core processes of AD, at least not in the early phase of the disease. Analyses need to be repeated in other populations before an association can be established. Future studies should also include persons with AD symptomatology and follow the CSF pathology longitudinally.
